Related Experiment Video
Updated: Feb 22, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025
Henrik Cordes1, Pieter Annaert2, Pavel Balazki3
1Research Pharmacometrics, Sanofi R&D, Frankfurt am Main, Germany.
None:
Developed at Bayer Technology Services, PK-Sim and MoBi transitioned into the Open Systems Pharmacology (OSP) Suite, released as free open-source software in 2017. An active community with stakeholders from academia, industries, and regulators contributes to the continuous improvement of open-source model-informed drug development (MIDD). This perspective summarizes the latest advancements presented at the second OSP Community Conference (OSP-CC) hosted from 29 to 30th of September 2025 at Sanofi Paris, that gathered over 100 attendees from more than 40 institutions.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Biopharmaceutics and Pharmacokinetics: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Pharmacogenetics and Pharmacogenomics: Overview

